HIGHLIGHTS
- who: Yu Rebecca Miao and collaborators from the DLBCLMM and DLBCL patient specimens were collected from patients treated at Stanford Cancer Center under the approval of Stanford institutional review board (protocol no., ). Healthy blood specimens were obtained from Stanford Blood Center under the same institutional review board protocol. In vivo animal studies were conducted under the approval of AAAPLAC at Stanford University. Sample sizes for animals were determined based on previously conducted in vivo studies for power calculations. All animals were randomly assigned to treatment groups. Samples were not excluded from studies except for animals that required . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.